Objective: To determine the clinical aspects of systemic vasculitis associa
ted with chronic myelomonocytic leukemia (CMML).
Methods: In this retrospective study, 8 patients suffering from systemic va
sculitis associated with CMML are described. The French and English literat
ure on systemic vasculitis associated with myelodysplasia was reviewed.
Results: All 8 patients had a systemic medium-sized vessel vasculitis which
fulfilled the American College of Rheumatology criteria for polyarteritis
nodosa in the setting of active CMML. Antineutrophil cytoplasmic antibodies
(ANCA) were negative in 7 patients. One patient had cytoplasmic ANCA by in
direct immunofluorescence without antiproteinase 3 or antimyeloperoxydase a
ntibodies on the enzyme-linked immunosorbent assay. At presentation, 6 pati
ents had fever of unknown origin, 5 had polymyalgia rheumatica, 3 had senso
ry hearing loss, and 4 had eosinophilia. None had viral infection or drug-a
ssociated vasculitis. Diagnostic procedures included renal or hepatic angio
graphy in 6 patients which showed microaneurysms in 4, skin and temporal ar
tery biopsy in 2 which showed vasculitis, and 1 postmortem examination whic
h showed gastroduodenal arteritis. All patients were treated with corticost
eroids, and 7 received immunosuppressive drugs. Death was attributable to v
asculitis in 2 cases, infection in 3, and other vasculitis-related causes i
n 2. In a review of the French-English literature, we found 11 similar case
s of ANCA-negative systemic vasculitis, generally associated with refractor
y anemia, with or without blast excess.
Conclusions: Systemic ANCA-negative polyarteritis nodosa-type vasculitis se
ems closely associated to CMML. Clinical presentation is nonspecific, and s
ystemic vasculitis should be suspected when a patient with myelodysplasia d
evelops atypical manifestations. Renal, gastrointestinal, or hepatic angiog
raphy are useful diagnostic procedures when more invasive biopsies should b
e avoided because of low platelet count. The prognosis of CMML-associated s
ystemic vasculitis is poor.